LUKÁŠ, M., HRUBÁ, V., REISSIGOVÁ, J., ČERNÁ, K., MACHKOVÁ, N., ĎURICOVÁ, D., KOLÁŘ, M., VLKOVÁ, K., ČERMÁKOVÁ, L., LUKÁŠ JR., M. Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study. Gastroenterologie a hepatologie. 2023, 77(4), 336-341. ISSN 1804-7874. Available: https://doi.org/10.48095/ccgh2023336.